Inorganic Chemistry, Vol.33, No.24, 5555-5570, 1994
Magnetostructural Correlations in Mu(2)-1,1-N-3 Bridged, Dinuclear Copper(II) Complexes .1. Ferromagnetic and Antiferromagnetic Coupling Associated with the Azide Bridge - X-Ray Crystal-Structures of (Cu-2(Dmptd)(Mu(2)-N-3)(Mu(2)-Cl)Cl-2)Center-Dot-CH3CN, (Cu-2(Dmptd)(Mu(2)-N-3)(2)(N-3)(2)), (Cu-2(Dip)(Mu(2)-N3)(Mu(2)-Cl)Cl-2)Center-Dot-0.5Ch3Oh, (Cu-2(Pap46Me-H)(Mu(2)-N-3)(N-3)(2))Center-Dot-0.33H2O, (Cu-2(PAP)(Mu(2)-N-3)Cl-3)Center-Dot-CH2Cl2, (Cu-2(PAP)(Mu(2)-N-3)(N-3)(NO3)(CH3OH))(NO3)Center-Dot-CH3OH, (Cu-2(Ppd3Me)(Mu(2)-N-3)Cl-3(H2O)(1.5)), and (Cu-2(PPD)(Mu(2)-N-3)(NO3)(3)(H2O)(1.6))
A series of dinuclear, mu(2)-1,1-azide bridged copper(II) complexes of seven tetradentate (N-4) diazine ligands has been prepared and characterized through spectroscopic, magnetochemical, and, in some cases, single-crystal X-ray diffraction studies : [Cu-2(DMPTD)(mu(2)-N-3)(mu(2)-X)X(2)]-CH3CN (X = Cl (1), Br (2)), [Cu-2(DMPTD)(mu(2)-N-3)(2)(N-3)(2)] (3), [Cu-2(DBITD)(mu(2)-N-3)(2)Cl-2].H2O (4), [Cu-2(DIP)(mu(2)-N-3)(mu(2)-X)X(2)].0.5CH(3)OH (X = Cl (5), X = Br (6)), [Cu-2(PAP46Me-H)(mu(2)-N-3)(N-3)(2)].0.33H(2)O (7), [Cu-2(PAP)(mu(2)-N-3)Cl-3].CH2Cl2 (8), [Cu-2(PAP)(mu(2)-N-3)(N-3)(NO3)(CH3OH)](NO3).CH3OH (9), [Cu-2(PPD3Me)(mu(2)-N-3)Cl-3(H2O)(1.5)] (10), [Cu-2(PPD3Me)(mu(2)-N-3)Br-3].0.5CH(3)CN (11), [Cu-2(PPD3Me)(mu(2)-N-3)(NO3)(3)].0.5CH(3)OH (12), and [Cu-2(PPD)(mu(2)-N-3)(NO3)(3)(H2O)(1.6)] (13) (DMPTD = 2,5-bis-((pyridylmethyl)thio) thiadiazole, DBITD = 2,5-bis(benzimidazolylmethyl)thio)thiadiazole, : [Cu-2(DMPTD)(mu(2)-N-3)(mu(2)-X)X(2)]-CH3CN (X = Cl (1), Br (2)), [Cu-2(DMPTD)(mu(2)-N-3)(2)(N-3)(2)] (3), [Cu-2(DBITD)(mu(2)-N-3)(2)Cl-2].H2O (4), [Cu-2(DIP)(mu(2)-N-3)(mu(2)-X)X(2)].0.5CH(3)OH (X = Cl (5), X = Br (6)), [Cu-2(PAP46Me-H)(mu(2)-N-3)(N-3)(2)].0.33H(2)O (7), [Cu-2(PAP)(mu(2)-N-3)Cl-3].CH2Cl2 (8), [Cu-2(PAP)(mu(2)-N-3)(N-3)(NO3)(CH3OH)](NO3).CH3OH (9), [Cu-2(PPD3Me)(mu(2)-N-3)Cl-3(H2O)(1.5)] (10), [Cu-2(PPD3Me)(mu(2)-N-3)Br-3].0.5CH(3)CN (11), [Cu-2(PPD3Me)(mu(2)-N-3)(NO3)(3)].0.5CH(3)OH (12), and [Cu-2(PPD)(mu(2)-N-3)(NO3)(3)(H2O)(1.6)] (13) (DMPTD = 2,5-bis-((pyridylmethyl)thio) thiadiazole, DBITD = 2,5-bis(benzimidazolylmethyl)thio)thiadiazole, : [Cu-2(DMPTD)(mu(2)-N-3)(mu(2)-X)X(2)]-CH3CN (X = Cl (1), Br (2)), [Cu-2(DMPTD)(mu(2)-N-3)(2)(N-3)(2)] (3), [Cu-2(DBITD)(mu(2)-N-3)(2)Cl-2].H2O (4), [Cu-2(DIP)(mu(2)-N-3)(mu(2)-X)X(2)].0.5CH(3)OH (X = Cl (5), X = Br (6)), [Cu-2(PAP46Me-H)(mu(2)-N-3)(N-3)(2)].0.33H(2)O (7), [Cu-2(PAP)(mu(2)-N-3)Cl-3].CH2Cl2 (8), [Cu-2(PAP)(mu(2)-N-3)(N-3)(NO3)(CH3OH)](NO3).CH3OH (9), [Cu-2(PPD3Me)(mu(2)-N-3)Cl-3(H2O)(1.5)] (10), [Cu-2(PPD3Me)(mu(2)-N-3)Br-3].0.5CH(3)CN (11), [Cu-2(PPD3Me)(mu(2)-N-3)(NO3)(3)].0.5CH(3)OH (12), and [Cu-2(PPD)(mu(2)-N-3)(NO3)(3)(H2O)(1.6)] (13) (DMPTD = 2,5-bis-((pyridylmethyl)thio) thiadiazole, DBITD = 2,5-bis(benzimidazolylmethyl)thio)thiadiazole, : [Cu-2(DMPTD)(mu(2)-N-3)(mu(2)-X)X(2)]-CH3CN (X = Cl (1), Br (2)), [Cu-2(DMPTD)(mu(2)-N-3)(2)(N-3)(2)] (3), [Cu-2(DBITD)(mu(2)-N-3)(2)Cl-2].H2O (4), [Cu-2(DIP)(mu(2)-N-3)(mu(2)-X)X(2)].0.5CH(3)OH (X = Cl (5), X = Br (6)), [Cu-2(PAP46Me-H)(mu(2)-N-3)(N-3)(2)].0.33H(2)O (7), [Cu-2(PAP)(mu(2)-N-3)Cl-3].CH2Cl2 (8), [Cu-2(PAP)(mu(2)-N-3)(N-3)(NO3)(CH3OH)](NO3).CH3OH (9), [Cu-2(PPD3Me)(mu(2)-N-3)Cl-3(H2O)(1.5)] (10), [Cu-2(PPD3Me)(mu(2)-N-3)Br-3].0.5CH(3)CN (11), [Cu-2(PPD3Me)(mu(2)-N-3)(NO3)(3)].0.5CH(3)OH (12), and [Cu-2(PPD)(mu(2)-N-3)(NO3)(3)(H2O)(1.6)] (13) (DMPTD = 2,5-bis-((pyridylmethyl)thio) thiadiazole, DBITD = 2,5-bis(benzimidazolylmethyl)thio)thiadiazole, : [Cu-2(DMPTD)(mu(2)-N-3)(mu(2)-X)X(2)]-CH3CN (X = Cl (1), Br (2)), [Cu-2(DMPTD)(mu(2)-N-3)(2)(N-3)(2)] (3), [Cu-2(DBITD)(mu(2)-N-3)(2)Cl-2].H2O (4), [Cu-2(DIP)(mu(2)-N-3)(mu(2)-X)X(2)].0.5CH(3)OH (X = Cl (5), X = Br (6)), [Cu-2(PAP46Me-H)(mu(2)-N-3)(N-3)(2)].0.33H(2)O (7), [Cu-2(PAP)(mu(2)-N-3)Cl-3].CH2Cl2 (8), [Cu-2(PAP)(mu(2)-N-3)(N-3)(NO3)(CH3OH)](NO3).CH3OH (9), [Cu-2(PPD3Me)(mu(2)-N-3)Cl-3(H2O)(1.5)] (10), [Cu-2(PPD3Me)(mu(2)-N-3)Br-3].0.5CH(3)CN (11), [Cu-2(PPD3Me)(mu(2)-N-3)(NO3)(3)].0.5CH(3)OH (12), and [Cu-2(PPD)(mu(2)-N-3)(NO3)(3)(H2O)(1.6)] (13) (DMPTD = 2,5-bis-((pyridylmethyl)thio) thiadiazole, DBITD = 2,5-bis(benzimidazolylmethyl)thio)thiadiazole,
Keywords:MAGNETIC-PROPERTIES;DIAZINE LIGANDS;SPECTROSCOPIC COMPARISONS;MOLECULAR-STRUCTURES;TETRADENTATE N-4;BINUCLEAR;EXCHANGE;STABILIZATION;PERCHLORATE;MONONUCLEAR